Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Acetaminophen recalled?

Yes — there is an active recall. 24 ongoing FDA recalls mention Acetaminophen (240 total). Check the affected lots below.

Recalls are matched by product description. A recall usually affects specific lots, not every package of Acetaminophen. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Acetaminophen recalls on record

none so far in 2026; 240 on record, newest first
Class III · Low risk

Oxycodone and Acetaminophen Tablets

Labeling: Incorrect or Missing Lot and/or Exp Date: Lot FG10517 is mislabeled on the primary container with Lot FG01517, shipper labels and invoices contain the correct lot number of FG10517.

Terminated Labeling / mix-up Mayne Pharma Inc NDC 68308-841-01 D-1129-2018
Class II · Moderate risk

RPC APAP Elixir

CGMP Deviations: Products are being recalled due to an out of specification total aerobic microbial count in a water sample.

Terminated Microbial contamination RIJ Pharmaceutical LLC NDC 53807-129-16 D-0847-2018
Class II · Moderate risk

RPC Children's Non-Aspirin

CGMP Deviations: Products are being recalled due to an out of specification total aerobic microbial count in a water sample.

Terminated Microbial contamination RIJ Pharmaceutical LLC NDC 53807-129-04 D-0845-2018
Class II · Moderate risk

Acetaminophen 300 mg with Codeine Phosphate 30 mg tablets

Labeling: Not Elsewhere Classified: due to a labeled declaration of; Store at 15¿C to 30¿C (59¿F to 86¿F) which differs from the original manufacturer declaration of; Store at 20¿C to 25¿C (68¿F to 77¿F).

Terminated Labeling / mix-up Prescript Pharmaceuticals, Inc. D-0809-2018
Class II · Moderate risk

Acetaminophen 300 mg with Codeine Phosphate 30 mg tablets

Labeling: Not Elsewhere Classified: due to a labeled declaration of; Store at 15¿C to 30¿C (59¿F to 86¿F) which differs from the original manufacturer declaration of; Store at 20¿C to 25¿C (68¿F to 77¿F).

Terminated Labeling / mix-up Prescript Pharmaceuticals, Inc. D-0806-2018
Class II · Moderate risk

Ninjacof-A

Microbial contamination of Non-sterile Products; potential B. cepacia contamination

Terminated Microbial contamination Centurion Labs, LLC NDC 23359-033-16 D-1141-2017
Class II · Moderate risk

Ofirmev (Acetaminophen)

Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.

Terminated Labeling / mix-up Advanced Pharma Inc. D-0800-2017
Class II · Moderate risk

Ninjacof-A

CGMP Deviations: Recall initiated as a precautionary measure due to a potential risk of product contamination with the bacteria B. cepacia.

Terminated Microbial contamination Pharmatech LLC NDC 23359-033-16 D-1522-2016
Class II · Moderate risk

All Midrin

Lack of Processing Controls

Terminated cGMP deviation Reliable Rexall-A Compounding Pharmacy D-1110-2016
Class I · High risk

Mucinex Fast-Max Cold & Sinus

Labeling: Label Mix-Up; Bottles of Mucinex Fast-Max liquid are correctly labeled on the front of the label, however the back of the bottle where the Drug Facts labeling is, is missing certain Active Ingredients such as acetaminophen, phenylephrine, dextromethorphan, diphenhydramine, and/or guaifenesin. As a result certain safety warnings associated with those ingredients may also be missing.

Terminated Labeling / mix-up Reckitt Benckiser LLC NDC 63824-016-66 D-1365-2015
Class I · High risk

Mucinex Fast Max Night Time Cold & Flu

Labeling: Label Mix-Up; Bottles of Mucinex Fast-Max liquid are correctly labeled on the front of the label, however the back of the bottle where the Drug Facts labeling is, is missing certain Active Ingredients such as acetaminophen, phenylephrine, dextromethorphan, diphenhydramine, and/or guaifenesin. As a result certain safety warnings associated with those ingredients may also be missing.

Terminated Labeling / mix-up Reckitt Benckiser LLC NDC 63824-500-66 D-1364-2015